Biochanin
CAS 491-80-5
Biochanin (CAS 491-80-5) is a pharmaceutical compound with 7 bioactivity targets and 0 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Bioactivity & Target Interactions
Target-level activity records with assay counts, activity type, and measured value where present.
| Target | Activity | Value | Assays | Organism |
|---|---|---|---|---|
| - | Potency | 15890.983132530122 nM | 62 | - |
| - | GI50 | 10000 nM | 33 | - |
| - | IC50 | 37333.11034482758 nM | 28 | - |
| - | Ki | 6743.25 nM | 10 | - |
| - | IC50 | 39.1875 ug.mL-1 | 8 | - |
| - | EC50 | 21490.14285714286 nM | 7 | - |
| - | MIC | 64 ug.mL-1 | 4 | - |
IUPHAR Ligand-Target Data
Curated ligand-target interaction rows with action, affinity, and literature identifiers.
| Target | Action | Affinity | PubMed |
|---|---|---|---|
| Estrogen-related receptor-α ESRRA |
Agonist | - | 14638870 |
| Estrogen-related receptor-β ESRRB |
Agonist | - | 14638870 |
| Estrogen-related receptor-γ ESRRG |
Agonist | - | 14638870 |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Biochanin used for in pharmaceutical contexts?
Biochanin (CAS 491-80-5) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Biochanin?
No adverse-event association or SIDER side-effect rows are rendered for Biochanin in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Biochanin also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Biochanin A with EU status "permitted".
What clinical phase is Biochanin in?
No phase 1-4 clinical development badge is rendered for Biochanin because the matched compound identifier rows do not contain a max-phase value.